ACB240705P6000
- 1.57
- +0.15+10.56%
Aurora Cannabis Newsroom
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts about the president's electability circulate, questions around
Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With Neutral
Aurora Cannabis (NASDAQ:ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned marijuana stock analyst from Zuanic & Associates, has init
Shares of Cannabis Stocks Are Trading Lower. The Sector May Be Moving as Investors Assess Thursday's Presidential Debate and 2024 Election Outlook.
Shares of Cannabis Stocks Are Trading Lower. The Sector May Be Moving as Investors Assess Thursday's Presidential Debate and 2024 Election Outlook.
Zuanic & Associates Initiates Coverage On Aurora Cannabis With Neutral Rating
Zuanic & Associates analyst Pablo Zuanic initiates coverage on Aurora Cannabis (NASDAQ:ACB) with a Neutral rating.
Canadian Vs. U.S. Cannabis Companies: Who Is Winning The Market Race To Weed Profits?
The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market dynamics and regulatory environments. According to rec
Roth MKM Maintains Aurora Cannabis(ACB.US) With Hold Rating, Cuts Target Price to $5.86
Roth MKM analyst William Kirk maintains $Aurora Cannabis(ACB.US)$ with a hold rating, and adjusts the target price from $5.9 to $5.86.According to TipRanks data, the analyst has a success rate of 41.8
Better Growth Stock: Aurora Cannabis or Tilray Brands?
Aurora Cannabis Inc. Price Target Cut to C$11.00/Share From C$12.50 by ATB Capital
Aurora Cannabis Inc. Price Target Cut to C$11.00/Share From C$12.50 by ATB Capital
Canaccord Genuity Maintains Buy on Aurora Cannabis, Raises Price Target to C$9
Canaccord Genuity analyst Matt Bottomley maintains Aurora Cannabis (TSX:ACB) with a Buy and raises the price target from C$8 to C$9.
Aurora Cannabis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/16/2023 -80.93% CIBC $1.75 → $1 Maintains Neutral 06/15/2023 -84.75% Canaccord Genuity $1.5 → $0.8 Main
CCORF Maintains Aurora Cannabis(ACB.US) With Buy Rating, Raises Target Price to $6.56
CCORF analyst Matt Bottomley maintains $Aurora Cannabis(ACB.US)$ with a buy rating, and adjusts the target price from $5.9 to $6.56.According to TipRanks data, the analyst has a success rate of 45.2%
Marijuana Stock Movers For June 20, 2024
GAINERS:Global Hemp Group (OTC:GBHPF) shares closed up 126.67% at $0.07Belgravia Hartford Cap (OTC:BLGVF) shares closed up 70.92% at $0.02MJ Holdings (OTC:MJNE) shares closed up 17.65% at $0.011933 In
Aurora Cannabis (ACB) Q4 2024 Earnings Call Transcript
Toronto Stocks Advance, Empire Shares Up on Adjusted Profit, Revenue Beats
By Adriano Marchese Stocks in Toronto were moderately higher Thursday. The majority of the push came from health tech and materials stocks, followed by energy and communications. Of the laggards, ut
Earnings Call Summary | Aurora Cannabis(ACB.US) Q4 2024 Earnings Conference
The following is a summary of the Aurora Cannabis Inc. (ACB) Q4 2024 Earnings Call Transcript:Financial Performance:Net revenue for Aurora Cannabis increased by 21% on a trailing 12-month basis.Adjust
Aurora Cannabis Inc. (ACB) Q4 2024 Earnings Call Transcript
Aurora Cannabis Inc. (ACB) Q4 2024 Earnings Call Transcript
Aurora Cannabis Falls Short of Revenue Target and Stock Drops
By Steve Gelsi Revenue rises 5% to C$67.4 million but misses C$69.5 million analyst estimate. Aurora Cannabis Inc.'s stock fell nearly 6% on Thursday after the Canadian marijuana company fell short
Stocks in Play: Aurora Cannabis Inc.
Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced its financial and operational results Thursday for the fourth quarter and fiscal year 2024.The Alberta-based cannabis giant noted the year-over-ye
Aurora Cannabis Inc. (ACB) Surpasses Q4 Earnings Estimates